Literature DB >> 33322677

Retrospective Definition of Clostridioides difficile PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study.

Manisha Goyal1, Lysiane Hauben2, Hannes Pouseele3, Magali Jaillard4, Katrien De Bruyne2, Alex van Belkum1, Richard Goering5.   

Abstract

Clostridioides difficile is a cause of health care-associated infections. The epidemiological study of C. difficile infection (CDI) traditionally involves PCR ribotyping. However, ribotyping will be increasingly replaced by whole genome sequencing (WGS). This implies that WGS types need correlation with classical ribotypes (RTs) in order to perform retrospective clinical studies. Here, we selected genomes of hyper-virulent C. difficile strains of RT001, RT017, RT027, RT078, and RT106 to try and identify new discriminatory markers using in silico ribotyping PCR and De Bruijn graph-based Genome Wide Association Studies (DBGWAS). First, in silico ribotyping PCR was performed using reference primer sequences and 30 C. difficile genomes of the five different RTs identified above. Second, discriminatory genomic markers were sought with DBGWAS using a set of 160 independent C. difficile genomes (14 ribotypes). RT-specific genetic polymorphisms were annotated and validated for their specificity and sensitivity against a larger dataset of 2425 C. difficile genomes covering 132 different RTs. In silico PCR ribotyping was unsuccessful due to non-specific or missing theoretical RT PCR fragments. More successfully, DBGWAS discovered a total of 47 new markers (13 in RT017, 12 in RT078, 9 in RT106, 7 in RT027, and 6 in RT001) with minimum q-values of 0 to 7.40 × 10-5, indicating excellent marker selectivity. The specificity and sensitivity of individual markers ranged between 0.92 and 1.0 but increased to 1 by combining two markers, hence providing undisputed RT identification based on a single genome sequence. Markers were scattered throughout the C. difficile genome in intra- and intergenic regions. We propose here a set of new genomic polymorphisms that efficiently identify five hyper-virulent RTs utilizing WGS data only. Further studies need to show whether this initial proof-of-principle observation can be extended to all 600 existing RTs.

Entities:  

Keywords:  C. difficile; CDI; GWAS; WGS; in silico PCR; markers; ribotyping; unitigs

Year:  2020        PMID: 33322677      PMCID: PMC7764247          DOI: 10.3390/diagnostics10121078

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  44 in total

Review 1.  How to: Surveillance of Clostridium difficile infections.

Authors:  M Krutova; P Kinross; F Barbut; A Hajdu; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2017-12-20       Impact factor: 8.067

Review 2.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Reference assays for Clostridium difficile infection: one or two gold standards?

Authors:  Timothy Planche; Mark Wilcox
Journal:  J Clin Pathol       Date:  2010-11-30       Impact factor: 3.411

4.  Clostridium difficile infection in Europe: a hospital-based survey.

Authors:  Martijn P Bauer; Daan W Notermans; Birgit H B van Benthem; Jon S Brazier; Mark H Wilcox; Maja Rupnik; Dominique L Monnet; Jaap T van Dissel; Ed J Kuijper
Journal:  Lancet       Date:  2011-01-01       Impact factor: 79.321

Review 5.  The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis.

Authors:  N Shetty; M W D Wren; P G Coen
Journal:  J Hosp Infect       Date:  2010-12-08       Impact factor: 3.926

Review 6.  Molecular methods for detecting and typing of Clostridium difficile.

Authors:  Deirdre A Collins; Briony Elliott; Thomas V Riley
Journal:  Pathology       Date:  2015-04       Impact factor: 5.306

7.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

Review 8.  Current status of Clostridium difficile infection epidemiology.

Authors:  Fernanda C Lessa; Carolyn V Gould; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

Review 9.  The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.

Authors:  Nienke Z Borren; Shadi Ghadermarzi; Susan Hutfless; Ashwin N Ananthakrishnan
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

10.  Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; David Griffiths; Brian Shine; Sarah Oakley; Lily O'Connor; John Finney; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Tim E A Peto
Journal:  Clin Infect Dis       Date:  2013-03-05       Impact factor: 20.999

View more
  1 in total

1.  Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile.

Authors:  Helena M B Seth-Smith; Michael Biggel; Tim Roloff; Vladimira Hinic; Thomas Bodmer; Martin Risch; Carlo Casanova; Andreas Widmer; Rami Sommerstein; Jonas Marschall; Sarah Tschudin-Sutter; Adrian Egli
Journal:  Front Cell Infect Microbiol       Date:  2021-06-01       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.